Andrew J. Low

CD4-Dependent Characteristics of Coreceptor Use and HIV Type 1 V3 Sequence in a Large Population of Therapy-Naive Individuals (2008)

Low, Andrew J., Marchant, David, Brumme, Chanson J., Brumme, Zabrina L., Dong, Winnie, Sing, Tobias, ...

Improved detection of X4 virus by V3 genotyping: application to plasma RNA and proviral DNA (2008)

Moores, Andrew, Thielen, Alexander, Dong, Winnie, Low, Andrew J., Woods, Conan, Jensen, Mark, ...

Improved genotypic prediction of HIV-1 coreceptor usage by incorporating V2 loop sequence variation (2008)

Thielen, Alexander, Harrigan, P Richard, Low, Andrew J., Moores, A, Altmann, Andre, Bozek, Kasia, ...

Structural Descriptors of gp120 V3 Loop for the Prediction of HIV-1 Coreceptor Usage (2007)

Oliver Sander, Tobias Sing, Ingolf Sommer, Andrew J. Low, Peter K. Cheung, P. Richard Harrigan, ...

HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as coreceptor. Knowledge of coreceptor usage is critical for monitoring disease progression as well as...

Structural Descriptors of gp120 V3 Loop for the Prediction of HIV-1 Coreceptor Usage (2007)

Oliver Sander, Tobias Sing, Ingolf Sommer, Andrew J Low, Peter K Cheung, P Richard Harrigan, ...

HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as coreceptor. Knowledge of coreceptor usage is critical for monitoring disease progression as well as...

Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates (2007)

Low, Andrew J., Dong, Winnie, Chan, Dennison, Sing, Tobias, Swanstrom, Ronald, Jensen, Mark, ...

Objective: Integrating CCR5 antagonists into clinical practice would benefit from accurate assays of co-receptor usage (CCR5 versus CXCR4) with fast turnaround and low cost. Design: Published HIV...

Determining human immunodeficiency virus coreceptor use in a clinical setting: Degree of correlation between two phenotypic assays and a bioinformatic model (2007)

Skrabal, Katharina, Low, Andrew J., Dong, Winnie, Sing, Tobias, Cheung, Peter K., Mammano, Fabrizio, ...

Predicting HIV coreceptor usage on the basis of genetic and clinical covariates (2007)

Sing, Tobias, Low, Andrew J., Beerenwinkel, Niko, Sander, Oliver, Cheung, Peter K., Domingues, Francisco S., ...

Structural Descriptors of gp120 V3 Loop for the Prediction of {HIV-1} Coreceptor Usage (2007)

Sander, Oliver, Sing, Tobias, Sommer, Ingolf, Low, Andrew J., Cheung, Peter K., Harrigan, P. Richard, ...

HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as coreceptor. Knowledge of coreceptor usage is critical for monitoring disease progression as well as...

Structural Descriptors of gp120 V3 Loop for the Prediction of HIV-1 Coreceptor Usage

Sander, Oliver, Sing, Tobias, Sommer, Ingolf, Low, Andrew J, Cheung, Peter K, Harrigan, P. Richard, ...

HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as coreceptor. Knowledge of coreceptor usage is critical for monitoring disease progression as well as...

Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model▿

Skrabal, Katharina, Low, Andrew J., Dong, Winnie, Sing, Tobias, Cheung, Peter K., Mammano, Fabrizio, ...

Two recombinant phenotypic assays for human immunodeficiency virus (HIV) coreceptor usage and an HIV envelope genotypic predictor were employed on a set of clinically derived HIV type 1 (HIV-1)...